192 related articles for article (PubMed ID: 18020116)
1. A national survey of primary methamphetamine-related admissions to youth residential substance abuse treatment facilities in Canada, 2005 to 2006.
Callaghan RC; Tavares J; Taylor L; Veldhuizen S
Can J Psychiatry; 2007 Oct; 52(10):684-8. PubMed ID: 18020116
[TBL] [Abstract][Full Text] [Related]
2. Trends in primary methamphetamine-related admissions to youth residential substance abuse treatment facilities in Canada, 2005-2006 and 2009-2010.
Verdichevski M; Burns R; Cunningham JK; Tavares J; Callaghan RC
Can J Psychiatry; 2011 Nov; 56(11):696-700. PubMed ID: 22114924
[TBL] [Abstract][Full Text] [Related]
3. The clinical characteristics of adolescents reporting methamphetamine as their primary drug of choice: an examination of youth admitted to inpatient substance-abuse treatment in northern British Columbia, Canada, 2001-2005.
Callaghan RC; Brands B; Taylor L; Lentz T
J Adolesc Health; 2007 Mar; 40(3):286-9. PubMed ID: 17321434
[TBL] [Abstract][Full Text] [Related]
4. Admission to acute care hospitals for adolescent substance abuse: a national descriptive analysis.
Chisolm DJ; Kelleher KJ
Subst Abuse Treat Prev Policy; 2006 Jul; 1():17. PubMed ID: 16831225
[TBL] [Abstract][Full Text] [Related]
5. A national survey of substance abuse treatment for juvenile offenders.
Young DW; Dembo R; Henderson CE
J Subst Abuse Treat; 2007 Apr; 32(3):255-66. PubMed ID: 17383550
[TBL] [Abstract][Full Text] [Related]
6. Decline in adolescent treatment admissions for methamphetamine use in Cape Town.
Pluddemann A; Dada S; Parry C
S Afr Med J; 2013 Apr; 103(7):478-80. PubMed ID: 23802214
[TBL] [Abstract][Full Text] [Related]
7. Impact of Canadian federal methamphetamine precursor and essential chemical regulations on methamphetamine-related acute-care hospital admissions.
Callaghan RC; Cunningham JK; Victor JC; Liu LM
Drug Alcohol Depend; 2009 Dec; 105(3):185-93. PubMed ID: 19699042
[TBL] [Abstract][Full Text] [Related]
8. A case-matched comparison of readmission patterns between primary methamphetamine-using and primary cocaine-using adolescents engaged in inpatient substance-abuse treatment.
Callaghan R; Taylor L; Victor JC; Lentz T
Addict Behav; 2007 Dec; 32(12):3101-6. PubMed ID: 17618062
[TBL] [Abstract][Full Text] [Related]
9. Comparison of basic data for the National Survey of Residential Group Care Facilities: 1966-1982.
Dore MM; Young TM; Pappenfort DM
Child Welfare; 1984; 63(6):485-95. PubMed ID: 6510036
[TBL] [Abstract][Full Text] [Related]
10. Surge in treatment admissions related to methamphetamine use in Cape Town, South Africa: implications for public health.
Plüddemann A; Myers BJ; Parry CD
Drug Alcohol Rev; 2008 Mar; 27(2):185-9. PubMed ID: 18264880
[TBL] [Abstract][Full Text] [Related]
11. Do total smoking bans affect the recruitment and retention of adolescents in inpatient substance abuse treatment programs? A 5-year medical chart review, 2001-2005.
Callaghan RC; Brewster JM; Johnson J; Taylor L; Beach G; Lentz T
J Subst Abuse Treat; 2007 Oct; 33(3):279-85. PubMed ID: 17376637
[TBL] [Abstract][Full Text] [Related]
12. Distress tolerance as a predictor of early treatment dropout in a residential substance abuse treatment facility.
Daughters SB; Lejuez CW; Bornovalova MA; Kahler CW; Strong DR; Brown RA
J Abnorm Psychol; 2005 Nov; 114(4):729-34. PubMed ID: 16351393
[TBL] [Abstract][Full Text] [Related]
13. Older admissions to substance abuse treatment in 2001.
Arndt S; Gunter TD; Acion L
Am J Geriatr Psychiatry; 2005 May; 13(5):385-92. PubMed ID: 15879587
[TBL] [Abstract][Full Text] [Related]
14. The Client Satisfaction Questionnaire-8: Psychometric properties in a cross-sectional survey of people attending residential substance abuse treatment.
Kelly PJ; Kyngdon F; Ingram I; Deane FP; Baker AL; Osborne BA
Drug Alcohol Rev; 2018 Jan; 37(1):79-86. PubMed ID: 28480521
[TBL] [Abstract][Full Text] [Related]
15. Mothers in substance abuse treatment: differences in characteristics based on involvement with child welfare services.
Grella CE; Hser YI; Huang YC
Child Abuse Negl; 2006 Jan; 30(1):55-73. PubMed ID: 16406024
[TBL] [Abstract][Full Text] [Related]
16. Client-Provider relationship in comprehensive substance abuse treatment: differences in residential and nonresidential settings.
Shin HC; Marsh JC; Cao D; Andrews CM
J Subst Abuse Treat; 2011 Dec; 41(4):335-46. PubMed ID: 21871770
[TBL] [Abstract][Full Text] [Related]
17. Correlations between population levels of prescription opioid use and prescription-opioid-related substance use treatment admissions in the USA and Canada since 2001.
Fischer B; Nakamura N; Urbanoski K; Rush B; Rehm J
Public Health; 2012 Sep; 126(9):749-51. PubMed ID: 22770736
[No Abstract] [Full Text] [Related]
18. Seclusion and restraint practices in residential treatment facilities for children and youth.
Brown JD; Barrett K; Ireys HT; Allen K; Pires SA; Blau G; Azur M
Am J Orthopsychiatry; 2012 Jan; 82(1):87-90. PubMed ID: 22239397
[TBL] [Abstract][Full Text] [Related]
19. Changes in services and structure in community residential treatment facilities for substance abuse patients.
Timko C; Lesar M; Engelbrekt M; Moos RH
Psychiatr Serv; 2000 Apr; 51(4):494-8. PubMed ID: 10737825
[TBL] [Abstract][Full Text] [Related]
20. Comparing inmate perceptions of two residential substance abuse treatment programs.
Stohr MK; Hemmens C; Shapiro B; Chambers B; Kelley L
Int J Offender Ther Comp Criminol; 2002 Dec; 46(6):699-714. PubMed ID: 12491846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
